Abbott Laboratories (ABT) Financials
Abbott Laboratories (ABT) Historical Financial Statements and Key Metrics for 1985 - 2021
Full Abbott Laboratories financials for 1985 - 2021 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Abbott Laboratories Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2021-Mar-31 | 10,456 | 6,055 (57.9 %) | 2,109 (20.2 %) | 1,793 (17.1 %) | 3,043 | 1.00 |
| 2020-Dec-31 | 10,701 | 6,208 (58.0 %) | 2,432 (22.7 %) | 2,162 (20.2 %) | 3,298 | 1.20 |
| 2020-Sep-30 | 8,853 | 4,887 (55.2 %) | 1,495 (16.9 %) | 1,232 (13.9 %) | 2,303 | 0.69 |
| 2020-Jun-30 | 7,328 | 4,065 (55.5 %) | 672 (9.2 %) | 537 (7.3 %) | 1,497 | 0.30 |
| 2020-Mar-31 | 7,726 | 4,445 (57.5 %) | 758 (9.8 %) | 564 (7.3 %) | 1,586 | 0.31 |
| 2019-Dec-31 | 8,314 | 4,880 (58.7 %) | 1,389 (16.7 %) | 1,049 (12.6 %) | 2,145 | 0.59 |
| 2019-Sep-30 | 8,076 | 4,718 (58.4 %) | 1,198 (14.8 %) | 960 (11.9 %) | 1,952 | 0.53 |
Full historical income statements for 1985 - 2021 is included in the
US Historical Financials dataset.
Abbott Laboratories Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2021-Mar-31 | 72,785 | 38,997 | 18,444 | 33,562 | 8,372 |
| 2020-Dec-31 | 72,548 | 39,545 | 18,747 | 33,003 | 7,148 |
| 2020-Sep-30 | 69,043 | 37,448 | 18,563 | 31,595 | 4,731 |
| 2020-Jun-30 | 68,776 | 37,978 | 19,679 | 30,798 | 5,037 |
| 2020-Mar-31 | 66,777 | 36,350 | 18,272 | 30,427 | 3,668 |
| 2019-Dec-31 | 67,887 | 36,586 | 18,139 | 31,301 | 4,140 |
| 2019-Sep-30 | 68,539 | 36,520 | 19,097 | 32,019 | 4,335 |
Full historical balance sheet data for 1985 - 2021 is included in the
US Historical Financials dataset.
Abbott Laboratories Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2021-Mar-31 | 2,637 | -422 | -967 | 2,240 |
| 2020-Dec-31 | 3,798 | -731 | -787 | 3,119 |
| 2020-Sep-30 | 2,066 | -472 | -1,915 | 1,570 |
| 2020-Jun-30 | 1,322 | -619 | 658 | 680 |
| 2020-Mar-31 | 715 | -393 | -735 | 355 |
| 2019-Dec-31 | 2,416 | -489 | -2,185 | 1,982 |
| 2019-Sep-30 | 1,948 | -432 | -513 | 1,547 |
Full historical cash flow data for 1985 - 2021 is included in the
US Historical Financials dataset.
Abbott Laboratories Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2021-Mar-31 | 212,937 | 223,327 | 20.37 | 29.69 | 6.34 |
| 2020-Dec-31 | 193,932 | 205,841 | 18.12 | 22.43 | 5.88 |
| 2020-Sep-30 | 192,886 | 206,969 | 21.79 | 39.14 | 6.10 |
| 2020-Jun-30 | 161,880 | 176,796 | 22.09 | 75.36 | 5.26 |
| 2020-Mar-31 | 139,580 | 154,475 | 18.07 | 61.87 | 4.59 |
| 2019-Dec-31 | 153,091 | 167,370 | 18.41 | 36.48 | 4.89 |
| 2019-Sep-30 | 147,967 | 162,973 | 18.32 | 38.53 | 4.62 |
Full historical valuation and operating metrics for 1985 - 2021 are included in the
US Historical Financials dataset.